Zacks Investment Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,606
Closed -$827K 778
2016
Q2
$827K Sell
10,606
-93,802
-90% -$6.69M 0.03% 367
2016
Q1
$5.74M Sell
104,408
-51,411
-33% -$2.8M 0.18% 129
2015
Q4
$9.63M Sell
155,819
-1,116
-0.7% -$70.4K 0.31% 92
2015
Q3
$9.9M Sell
156,935
-1,569
-1% -$112K 0.35% 92
2015
Q2
$11.6M Buy
158,504
+3,322
+2% +$240K 0.37% 88
2015
Q1
$10.1M Sell
155,182
-3,316
-2% -$220K 0.32% 96
2014
Q4
$10.3M Sell
158,498
-3,270
-2% -$211K 0.33% 98
2014
Q3
$9.73M Sell
161,768
-14,709
-8% -$961K 0.34% 92
2014
Q2
$12.3M Buy
176,477
+100,178
+131% +$6.49M 0.44% 74
2014
Q1
$4.99M Sell
76,299
-1,335
-2% -$86.9K 0.18% 137
2013
Q4
$4.81M Buy
+77,634
New +$4.5M 0.19% 137

Other funds holding STJ

Zacks Investment Management's STJ Position: Q3 2016 in Review

Zacks Investment Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 10,606 shares — an estimated $827K sold.

Zacks Investment Management first reported a position in STJ in Q4 2013 and held it in 11 quarters. The position peaked at $12.3M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Zacks Investment Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Zacks Investment Management sold 10,606 St Jude Medical shares in Q3 2016, an estimated $827K.
  • Zacks Investment Management first reported a position in St Jude Medical in Q4 2013 and held it in 11 quarters.
  • Zacks Investment Management's St Jude Medical position peaked at $12.3M in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Zacks Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.